Guardant Health
$174.75Change from previous close: −2.02%Absolute change: −$3.61
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $23.45B
- Enterprise value
- $24.09B
- Forward P/E
- -439.0
- Price/sales
- 19.8
- EV/EBITDA
- -56.0
- EV/revenue
- 20.4
Profitability and growth
- Gross margin
- 65.0%
- Operating margin
- -38.2%
- Net margin
- -38.3%
- ROA
- -18.1%
- Revenue growth (year over year)
- 44.3%
Financial health
- Total cash
- $1.05B
- Total debt
- $1.7B
- Current ratio
- 4.03
- Quick ratio
- 3.53
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $197.04
- Median price target
- $200.00
- High price target
- $225.00
- Low price target
- $105.00
- Analysts with a price target
- 25
- Consensus
- Strong buy
- Forward EPS
- -$0.40
- EPS estimate, current year
- -$1.47
Shares and trading
- Beta
- 1.58
- Average volume
- 2.03M
- Shares outstanding
- 134.2M
- Float
- 129.48M
- Institutional ownership
- 100.9%
- Insider ownership
- 4.0%
- Short interest (% of float)
- 8.6%
- Short ratio (days)
- 5.70